This inventor holds 50 USPTO granted patents and 6 published patent applications, plus 4 CIPO patents and 8 EPO patents, primarily in Vaccine Formulations. Top assignees: Corixa Corporation, Takeda Vaccines, Inc., Access to Advanced Health Institute. Active years: 1998-2025.
Location History:
- Bozeman, MT (US) (2016)
- Federal Way, WA (US) (1998 - 2023)
- Cambridge, MA (US) (2018 - 2023)
Company Filing History:
30 out of 247 
13 out of 72 
3 out of 19 Years Active: 1998-2025
Areas of Expertise:
Title: Thomas S. Vedvick: Pioneering Innovator in Vaccine Technologies
Introduction:
Thomas S. Vedvick, a prolific inventor based in Federal Way, WA (US), is renowned for his relentless pursuit of innovation and his passion for creating solutions to complex problems. With an impressive portfolio of 49 patents, Vedvick's expertise in the field of vaccine technologies has solidified his position as a respected figure in the industry. His unwavering dedication to pushing the boundaries of what is possible continues to inspire future generations of inventors.
Latest Patents:
1. Method of conferring a protective immune response to Norovirus: Vedvick's invention focuses on vaccine compositions comprising Norovirus antigens and adjuvants, specifically mixtures of monovalent VLPs and multivalent VLPs. This method aims to confer protective immunity to Norovirus infections in human subjects.
2. Single vial vaccine formulations: Vedvick's groundbreaking invention introduces thermostable lyophilized formulations, including vaccines and pharmaceutical compositions designed to induce or enhance an immune response. The formulations consist of an antigen and/or an adjuvant, a metabolizable oil, and a cake-forming excipient.
Career Highlights:
Throughout his career, Vedvick has made significant contributions to the field of vaccine technologies. He has worked with esteemed companies such as Corixa Corporation and Takeda Vaccines, Inc. His innovative approach and dedication to scientific advancement have been instrumental in shaping the landscape of vaccine development.
Collaborations:
Vedvick has collaborated with notable professionals in the industry, including Yasir A. W. Skeiky and Davin C. Dillon. Together, they have worked on pioneering projects that have led to the creation of cutting-edge vaccine technologies and solutions.
Conclusion:
Thomas S. Vedvick's remarkable journey as an inventor showcases his unwavering commitment to innovation and his profound impact on the field of vaccine technologies. His pioneering spirit and dedication to finding solutions to challenging problems serve as a source of inspiration for aspiring inventors worldwide. Vedvick's legacy will undoubtedly continue to shape and inspire the future of scientific innovation.